|
| Effect of Naoxin Duotai capsule in treating syndrome of excessive rising of liver-yang and obstruction of collaterals with blood stasis in the recovery stage of Ischemia Stroke |
| Hits 1579 Download times 1792 Received:November 29, 2006 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2007.02.06 |
| Key Words
the recovery stage of ischemia stroke;the syndrome of excessive rising of liver-yang;the syndrome of obstruction of collaterals with blood stasis;Naoxin Duotai capsule;clinical research |
| Author Name | Affiliation | | HAN Li | The First Hospital Affilated to Tianjin Hospital of TCM, Tianjin 300193, China |
|
| Abstract
|
| [Objective] To evaluate the effectiveness and safety of Naoxin(brain and heart) Duotai capsule(NXDT) in treating the syndrome of excessive rising of liver-yang and obstruction of collaterals with blood stasis in the recovery stage of ischemia stroke and explore the dose-effect relationship. [Methods] A multiple-center research of randomly and double-blind design, single simulation, negative control of basic treatment with placebo(zero dose) was carried out. [Results] The high and low dosage of NXDT may obviously improve the neurologic impairment, TCM syndrome and Barthel indexes. The adverse effect wasn’t existed in the high and low dosage of NXDT group. [Conclusions] The Naoxin Duotai capsule has a better safety and curative effect in treating the syndrome of excessive rising of liver-yang and obstruction of collaterals with blood stasis in patients with ischemia stroke in recovery stage. The recommended clinical dosage is 60 mg daily. |
|
